analyst
VC
NASDAQ · VCYT
Veracyte, Inc.
Healthcare · Biotechnology
$40.14
Down-$0.45 (-1.12%)
Updated Sep 16, 2026, 6:18 PM
SID Score
4.4/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 3.34B
- P/E ratio
- 109.61
- Dividend yield
- 0.00%
- 52-week range
- $29.46 – $60.91
- Volume
- 1.76M
- Avg. volume
- 966.7K
Price performance
VCYT price history
1M range · 20 trading sessions · Daily adjusted prices
VCYT closed at $40.14 after 20 trading sessions, down 1.33% for the selected period.
- Last close
- $40.14
- Period change
- -1.33%
- Period low
- $40.14
- Period high
- $45.25
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $40.83 | $42.36 | $39.095 | $40.14 | 1.76M |
| Sep 14, 2026 | $41.17 | $41.403 | $40.50 | $41.21 | 1.03M |
| Sep 11, 2026 | $42.61 | $42.66 | $40.79 | $40.87 | 1M |
| Sep 10, 2026 | $43.18 | $43.7799 | $41.64 | $42.03 | 849.42K |
| Sep 9, 2026 | $42.79 | $44.20 | $42.385 | $43.86 | 1.45M |
| Sep 8, 2026 | $41.81 | $43.28 | $41.57 | $42.45 | 962.03K |
| Sep 4, 2026 | $44.21 | $44.81 | $42.43 | $42.53 | 992.18K |
| Sep 3, 2026 | $45.36 | $45.99 | $44.12 | $44.67 | 673.67K |
| Sep 2, 2026 | $43.51 | $45.65 | $43.48 | $44.88 | 1.37M |
| Sep 1, 2026 | $42.97 | $43.74 | $42.28 | $43.43 | 873.01K |
| Aug 31, 2026 | $42.33 | $43.335 | $41.60 | $43.19 | 1.47M |
| Aug 28, 2026 | $45.205 | $45.55 | $43.32 | $43.34 | 1.68M |
| Aug 27, 2026 | $44.20 | $45.50 | $44.19 | $45.25 | 1.33M |
| Aug 26, 2026 | $43.78 | $44.52 | $43.25 | $44.29 | 2.18M |
| Aug 25, 2026 | $42.01 | $44.10 | $41.805 | $44.04 | 1.16M |
| Aug 24, 2026 | $42.00 | $42.067 | $41.02 | $41.47 | 1.17M |
| Aug 21, 2026 | $42.18 | $42.54 | $41.10 | $42.31 | 1.01M |
| Aug 20, 2026 | $41.67 | $42.445 | $41.05 | $41.79 | 980.36K |
| Aug 19, 2026 | $41.92 | $42.52 | $40.095 | $42.19 | 1.76M |
| Aug 18, 2026 | $41.80 | $42.35 | $40.35 | $40.68 | 1.14M |
Latest VCYT news
The latest Smart Investors Daily articles mentioning VCYT.
Stock researchResearch & News · SEC Filings
Loading stock research…